COMP <GO>
MTH vs ECG // 10Y YIELD & FRED MACRO BETA
Meritage Homes Corporation (NYSE) VS. Everus Construction Group Inc. (NYSE) • 15-METRIC TALLY: MTH 8
— ECG 5
▲ 10Y YIELD & FRED MACRO BETA LEADER: ECG
LAST: $69.01 (+7.04%) • MKT CAP: $4.20B
macro-sensitivity
1.05
LAST: $102.99 (+0.35%) • MKT CAP: $5.24B
macro-sensitivity
1.13
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MTH VS. ECG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MTH | ECG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 12.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.00% | 30.40% | -22.40 | ECG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.7x | 13.7x | -6.00 | MTH | /valuation <GO> |
| Free Cash Flow Yield | 2.20% | -0.21% | +2.41 | MTH | /fcf-yield <GO> |
| Operating Margin | 47.00% | 7.10% | +39.90 | MTH | /operating-margins <GO> |
| Net Profit Margin | 38.50% | 5.40% | +33.10 | MTH | /net-margins <GO> |
| Revenue Growth (YoY) | 8.80% | 31.50% | -22.70 | ECG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.88% | 0.00% | +2.88 | MTH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.70 | 6.47 | -3.77 | ECG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | MTH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.4 | 41.7 | +13.70 | MTH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.05 | 1.13 | -0.08 | ECG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.6x | 22.9x | -14.30 | MTH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.20B | $5.24B | -$1.04B | ECG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MTH REV | ECG REV | MTH GROSS % | ECG GROSS % | MTH FCF | ECG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.50B | $3.75B | — | 12.1% | $92.6M | -$11.7M |
| FY 2024 | $2.60B | $2.85B | — | 11.9% | -$256.2M | $35.1M |
| FY 2023 | $2.44B | $2.85B | — | — | $355.6M | $42.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MTH // BETA 1.05
ECG // BETA 1.13